Assessment of Mitochondrial Gene Activity in Dopaminergic Neuron Cultures Derived from Induced Pluripotent Stem Cells Obtained from Parkinson's Disease Patients
- Authors: Vetchinova A.S.1, Kapkaeva M.R.1, Mudzhiri N.M.1, Illarioshkin S.N.1
-
Affiliations:
- Research Center of Neurology
- Issue: Vol 17, No 4 (2023)
- Pages: 58-63
- Section: Original articles
- URL: https://ogarev-online.ru/2075-5473/article/view/251940
- DOI: https://doi.org/10.54101/ACEN.2023.4.7
- ID: 251940
Cite item
Abstract
Introduction. Induced pluripotent stem cells (iPSCs) culturing allows modelling of neurodegenerative diseases in vitro and discovering its early biomarkers.
Our objective was to evaluate the activity of genes involved in mitochondrial dynamics and functions in genetic forms of Parkinson's disease (PD) using cultures of dopaminergic neurons derived from iPSCs.
Materials and methods. Dopaminergic neuron cultures were derived by reprogramming of the cells obtained from PD patients with SNCA and LRRK2 gene mutations, as well as from a healthy donor for control. Expression levels of 112 genes regulating mitochondrial structure, dynamics, and functions were assessed by multiplex gene expression profiling using NanoString nCounter custom mitochondrial gene expression panel.
Results. When comparing the characteristics of the neurons from patients with genetic forms of PD to those of the control, we observed variations in the gene activity associated with the mitochondrial respiratory chain, the tricarboxylic acid cycle enzyme activities, biosynthesis of amino acids, oxidation of fatty acids, steroid metabolism, calcium homeostasis, and free radical quenching. Several genes in the cell cultures with SNCA and LRRK2 gene mutations exhibited differential expression. Moreover, these genes regulate mitophagy, mitochondrial DNA synthesis, redox reactions, cellular detoxification, apoptosis, as well as metabolism of proteins and nucleotides.
Conclusions. The changes in gene network expression found in this pilot study confirm the role of disrupted mitochondrial homeostasis in the molecular pathogenesis of PD. These findings may contribute to the development of biomarkers and to the search for new therapeutic targets for the treatment of SNCA- and LRRK2-associated forms of the disease.
Full Text
##article.viewOnOriginalSite##About the authors
Anna S. Vetchinova
Research Center of Neurology
Author for correspondence.
Email: annvet@mail.ru
ORCID iD: 0000-0003-3367-5373
Cand. Sci. (Biol.), Senior Researcher, Laboratory of Neurobiology and Tissue Engineering, Department of Molecular and Cellular Mechanisms of Neuroplasticity, Brain Science Institute
Russian Federation, MoscowMarina R. Kapkaeva
Research Center of Neurology
Email: annaly-nevrologii@neurology.ru
ORCID iD: 0000-0002-2833-2897
Researcher, Laboratory of Neurobiology and Tissue Engineering, Department of Molecular and Cellular Mechanisms of Neuroplasticity, Brain Science Institute
Russian Federation, MoscowNatalia M. Mudzhiri
Research Center of Neurology
Email: Mudzhirinm@gmail.com
ORCID iD: 0000-0002-3835-6622
Junior Researcher, Laboratory of Neuromorphology, Brain Science Institute
Russian Federation, MoscowSergey N. Illarioshkin
Research Center of Neurology
Email: annaly-nevrologii@neurology.ru
ORCID iD: 0000-0002-2704-6282
D. Sci. (Med.), Prof., RAS Full Member, Deputy Director for Science; Director, Brain Science Institute
Russian Federation, MoscowReferences
- Dorsey E.R., Bloem B.R. The Parkinson pandemic — a call to action. JAMA Neurol. 2018;75:9–10. doi: 10.1001/jamaneurol.2017.3299
- Chaudhuri K.R., Healy D.G., Schapira A.H. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5:235–2454. doi: 10.1016/S1474-4422(06)70373-8.
- MacDougall G., Brown L.Y., Kantor B. et al. The path to progress preclinical studies of age-related neurodegenerative diseases: a perspective on rodent and hiPSC-derived models. Mol. Ther. 2021;29(3):949–972. doi: 10.1016/j.ymthe.2021.01.001
- Geiss G.K., Bumgarner R.E., Birditt B. et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 2008;26(3):317–325. doi: 10.1038/nbt1385.
- Gentien D., Piqueret-Stephan L., Henry E. et al. Digital multiplexed gene expression analysis of mRNA and miRNA from routinely processed and stained cytological smears: a proof-of-principle study. Acta Cytol. 2021;65(1):88–98. doi: 10.1159/000510174
- Vazquez-Prokopec G.M., Bisanzio D., Stoddard S.T. et al. Using GPS technology to quantify human mobility, dynamic contacts and infectious disease dynamics in a resource-poor urban environment. PLoS One. 2013;8(4):e58802. doi: 10.1371/journal.pone.0058802
- Geiss G.K., Bumgarner R.E., Birditt B. et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 2008;26(3):317–325. doi: 10.1038/nbt1385
- Yu L., Bhayana S., Jacob N.K., Fadda P. Comparative studies of two generations of NanoString nCounter System. PLoS One. 2019;14(11):e0225505. doi: 10.1371/journal.pone.0225505
- Osellame L.D., Duchen M.R.. Defective quality control mechanisms and accumulation of damaged mitochondria link Gaucher and Parkinson diseases. Autophagy. 2013;9(10):1633–1635. doi: 10.4161/auto.25878
- Сухоруков В.С., Воронкова А.С., Литвинова Н.А. и др. Роль индивидуальных особенностей митохондриальной ДНК в патогенезе болезни Паркинсона. Генетика. 2020;56(4):392–400. Sukhorukov V.S., Voronkova A.S., Litvinova N.A. The role of individual features of mitochondrial DNA in the pathogenesis of Parkinson’s disease. Genetics. 2020;56(4):392–400. (In Russ.) doi: 10.31857/S0016675820040141
- Новосадова Е.В., Арсеньева Е.Л., Мануилова Е.С. и др. Исследование нейропротекторных свойств эндоканнабиноидов N-арахидоноил- дофамина и N-докозагексаеноилдофамина на нейрональных предшественниках человека, полученных из индуцированных плюрипотентных ство- ловых клеток человека. Биохимия. 2017;82(11):1732–1739. Novosadova E.V., Arsenyeva E.L., Manuilova E.S. et al. Neuroprotective properties of endocannabinoids N-arachidonoyl dopamine and N-docosahexaenoyl dopamine examined in neuronal precursors derived from human pluripotent stem cells. Biochemistry. 2017; 82: 1367–1372. (In Russ.) doi: 10.1134/S0006297917110141
- Novosadova E.V., Nenasheva V.V., Makarova I.V. et al. Parkinson's disease-associated changes in the expression of neurotrophic factors and their receptors upon neuronal differentiation of human induced pluripotent stem cells. J. Mol. Neurosci. 2020;70(4):514–521. doi: 10.1007/s12031-019-01450-5
- Abeti R., Abramov A.Y. Mitochondrial Ca2+ in neurodegenerative disorders. Pharmacol. Res. 2015;99:377–381. doi: 10.1016/j.phrs.2015.05.007
- Rothbauer U., Hofmann S., Mühlenbein N. et al. Role of the deafness dystonia peptide 1 (DDP1) in import of human Tim23 into the inner membrane of mitochondria. J. Biol. Chem. 2001;276(40):37327–37334. doi: 10.1074/jbc.M105313200
- Dolgacheva L., Fedotova E.I., Abramov A. et al. Alpha-synuclein and mitochondrial dysfunction in Parkinson's disease. Biological Membranes: Journal of Membrane and Cell Biology. 2017;34:4–14. doi: 10.1134/S1990747818010038
- Fernandez-Vizarra E., Zeviani M. Mitochondrial disorders of the OXPHOS system. FEBS Lett. 2021;595:1062–1106. doi: 10.1002/1873-3468.13995
- Kwong J.Q., Beal M.F., Manfredi G. The role of mitochondria in inherited neurodegenerative diseases. J. Neurochem. 2006;97(6):1659–1675. doi: 10.1111/j.1471-4159.2006.03990.x
- Allen S.P., Seehra R.S., Heath P.R. et al. Transcriptomic analysis of human astrocytes in vitro reveals hypoxia-induced mitochondrial dysfunction, modulation of metabolism, and dysregulation of the immune response. Int. J. Mol. Sci. 2020;21:8028. doi: 10.3390/ijms21218028
- Zhang Z., Yan J., Chang Y. et al. Hypoxia inducible factor-1 as a target for neurodegenerative diseases. Curr. Med. Chem. 2011;18(28):4335–4343. doi: 10.2174/092986711797200426
- de Brito O.M., Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature. 2008;456(7222):605–610. doi: 10.1038/nature07534
- Olichon A., Baricault L., Gas N. et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J. Biol. Chem. 2003;278(10):7743–7746. doi: 10.1074/jbc.C200677200
- Baker N., Patel J., Khacho M. Linking mitochondrial dynamics, cristae remodeling and supercomplex formation: how mitochondrial structure can regulate bioenergetics. Mitochondrion. 2019;49:259–268. doi: 10.1016/j.mito.2019.06.003
- Kim D., Hwang H.Y., Ji E.S. et al. Activation of mitochondrial TUFM ameliorates metabolic dysregulation through coordinating autophagy induction. Commun. Biol. 2021;4(1):1–17. doi: 10.1038/s42003-020-01566-0.
- Murata D., Arai K., Iijima M., Sesaki H. Mitochondrial division, fusion and degradation. J. Biochem. 2020;167(3):233–241. doi: 10.1093/jb/mvz106
Supplementary files
